CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Biotech is back, with H1 progress smoothing glide path through end of year: Truist

Positive
AI Analysis

Summary

Truist Securities reports biotech sector is on a positive trajectory following a prolonged downturn, with M&A activity rising, venture capital returning, and policy risks easing based on survey of sector leaders.

Importance:2/10
Sentiment:
0.70
Industry trendsM&AVenture capitalPolicyBiotech sector

Read the original article

Published by BioSpace on September 4, 2026 1:33 PM

Read Original